John D. Bonnet
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 12
- Peptidase Inhibition and Analysis 5
- Colorectal Cancer Treatments and Studies 3
- Hematology 20
- Multiple Myeloma Research and Treatments 17
- Co-authors
- Arthur Haut (7 shared papers)Raymond Alexanian (6 shared papers)Edmund A. Gehan (3 shared papers)James S. Hewlett (2 shared papers)Raymond W. Monto (2 shared papers)Stanley P. Balcerzak (3 shared papers)Dennis O. Dixon (6 shared papers)James K. Weick (3 shared papers)
- Journals
- Cancer (12 papers)Investigational New Drugs (6 papers)Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (1 paper)JAMA (1 paper)
- Partner nations
- United StatesPortugalEgypt
In The Last Decade
John D. Bonnet
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 85
- Hematology 745
- Oncology 1.0k
- Genetics 149
- Molecular Biology 620
- Gastroenterology 47
Countries citing papers authored by John D. Bonnet
This map shows the geographic impact of John D. Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Bonnet more than expected).
Fields of papers citing papers by John D. Bonnet
This network shows the impact of papers produced by John D. Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Bonnet. The network helps show where John D. Bonnet may publish in the future.
Co-authors
The 25 scholars most cited alongside John D. Bonnet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 182 | |
| 2 | 1972 | 163 | |
| 3 | 1995 | 131 | |
| 4 | 1976 | 127 | |
| 5 | 1991 | 125 | |
| 6 | 1983 | 113 | |
| 7 | 1977 | 107 | |
| 8 | 1986 | 66 | |
| 9 | 1984 | 64 | |
| 10 | 1983 | 62 | |
| 11 | 1988 | 61 | |
| 12 | 1991 | 49 | |
| 13 | 1990 | 40 | |
| 14 | 1983 | 40 | |
| 15 | 1979 | 40 | |
| 16 | 1978 | 36 | |
| 17 | 1990 | 32 | |
| 18 | 1960 | 32 | |
| 19 | Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. | 1982 | 27 |
| 20 | 1981 | 25 |
About John D. Bonnet
John D. Bonnet is a scholar working on Oncology, Hematology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Cancer Treatment and Pharmacology (12 papers), Cancer therapeutics and mechanisms (8 papers), Peptidase Inhibition and Analysis (5 papers), Colorectal and Anal Carcinomas (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Protein Degradation and Inhibitors (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Hematology (745 citations), Oncology (1.0k citations), Genetics (149 citations), Molecular Biology (620 citations) and Gastroenterology (47 citations). John D. Bonnet has collaborated with scholars based in United States, Portugal and Egypt. Frequent co-authors include Arthur Haut, Raymond Alexanian, Edmund A. Gehan, James S. Hewlett, Raymond W. Monto, Stanley P. Balcerzak, Dennis O. Dixon, James K. Weick, Geoffrey R. Weiss and Ronald L. Stephens. Their work appears in journals such as Cancer, Investigational New Drugs, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.